Related references
Note: Only part of the references are listed.Prevalence of Metabolic Syndrome in Patients With Psychotic Disorders in the Netherlands
Susanne G. Schorr et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia A Replication Study
Hans Mulder et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2009)
Olanzapine-induced weight gain is associated with the-759C/T and-697G/C polymorphisms of the HTR2C gene
B. R. Godlewska et al.
PHARMACOGENOMICS JOURNAL (2009)
Identifying people with metabolic syndrome in primary care by screening with a mailed tape measure A survey of 14,000 people in the Netherlands
Maureen van den Donk et al.
PREVENTIVE MEDICINE (2009)
Influence of 5-HT2c receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia
Olga O. Yevtushenko et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Lack of association between the-759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients
Y. -M. Park et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2008)
Beyond the Hype on the association between metabolic syndrome and atypical antipsychotics - The confounding effects of cohort, typical antipsychotics, severe mental illness, comedications, and comorbid substance use
Jose de Leon
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Association of the HTR2C gene and antipsychotic induced weight gain:: a meta-analysis
Vincenzo De Luca et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia
Hans Mulder et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
-759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment
Seunghyong Ryu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review
C. M. Bennett et al.
DIABETIC MEDICINE (2007)
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial and comparison with national estimates from NHANES III
JP McEvoy et al.
SCHIZOPHRENIA RESEARCH (2005)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment
GP Reynolds et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
Weight gain associated with the-759 C/T polymorphism of the 5HT2C receptor and olanzapine
VL Ellingrod et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
Clozapine-induced weight gain associated with the 5HT2C receptor-759C/T polymorphism
DD Miller et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
ARC-1, a sequence element complementary to an internal 18S rRNA segment, enhances translation efficiency in plants when present in the leader or intercistronic region of mRNAs
RZ Akbergenov et al.
NUCLEIC ACIDS RESEARCH (2004)
-759C/T genetic variation of 5HT2C receptor and clozapine-induced weight gain
SJ Tsai et al.
LANCET (2002)
Share Paper
